478 results about "Serum samples" patented technology

The invention relates to a construction method of a metabolic syndrome phlegm syndrome lipid metabolism characteristic diagnosis model. The construction method comprises the following steps: S1, acquiring a serum sample; s2, carrying out lipid metabolite analysis through a full-quantitative lipidomics formula; s3, carrying out primary screening on differential metabolites; s4, optimizing the characteristic indexes by using a random forest algorithm and stepwise regression; and S5, constructing a differential metabolite diagnosis model through Logistic regression analysis. By analyzing differential lipid metabolites of patients with MetS phlegm syndromes and non-phlegm syndromes, the invention reveals that abnormal accumulation of lipid and lipid metabolites may be the core pathological parenchyma of MetS phlegm syndromes. By integrating lipid metabonomics data, using a random forest algorithm, stepwise regression and other methods to screen feature difference lipid metabolites and construct a MetS phlegm syndrome specific diagnosis model, a novel combined biomarker and evidence-based basis are provided for early diagnosis of MetS phlegm syndromes, and a scientific basis can also be provided for objective diagnosis of traditional Chinese medicine phlegm syndromes.

The invention relates to a method for acquiring a biomarker for assisting CRLM early diagnosis. The method comprises the following steps: acquiring sequencing data, clinical information and metabonomics characteristics of a CRC sample; evaluating and determining a plurality of differentiated machine learning models; performing classification according to the determined machine learning model, and constructing a CRLM biomarker prediction model; screening candidate biomarkers according to the prediction model; and verifying the candidate biomarker at least according to the tissue slice and the serum sample, and determining a final biomarker.

The invention belongs to the technical field of liquid chromatography-mass spectrometry detection pretreatment, and particularly relates to a pretreatment method for liquid chromatography-tandem mass spectrometry analysis of pesticide and veterinary drug residues in serum, which comprises the following steps: (S1) carrying out heating reaction on Sc (III) salt, Cu (II) salt and 1H-pyrazole-4-formic acid (H2PyC) in a polar aprotic solvent, and cooling to obtain a green crystal, namely MOF-919; the chemical formula of the MOF-919 is [Sc < 3 > (mu3-O) (OH) < 3 >] [Cu3 (mu3-O) (mu-PyC) < 3 > (H2O) < 6 >] < 2 >; (S2) mixing the serum sample with an acetonitrile solution containing formic acid, carrying out ultrasonic treatment, vortex oscillation and centrifugation, taking supernate, and diluting the supernate with an aqueous solution containing formic acid to obtain a to-be-purified solution; and (S3) adding MOF-919 into the to-be-purified liquid, mixing, performing ultrasonic treatment, performing vortex oscillation, centrifuging, and taking supernate, thereby completing the pretreatment of the to-be-purified liquid. According to the method, the MOF-919 is used for adsorbing chemical pollutant residues in serum, especially phospholipids, so that the purpose of removing the chemical pollutant residues in blood is achieved. The method is simple and convenient to operate, small in organic solvent consumption and good in purification effect, and can be widely applied to residue analysis of chemical pollutants in serum.

The invention provides a method for detecting an external vesicle marker through high-flux nano plasma exciting light immune color development, and belongs to the technical field of human extracellular vesicles. After a serum sample is subjected to centrifugal treatment, the serum sample and a CD81 capture antibody substrate are incubated, and the particle size distribution of the vesicles is monitored in real time; a zwitterionic polymer modified gold nanoparticle LAM detection probe and a polyethylene glycol modified silver nanoparticle LprG detection probe are prepared to be specifically combined with a vesicle surface antigen, a chromogenic enhancement solution is adopted to induce a plasma resonance signal, and full-hole scanning imaging is carried out; and constructing a double-layer game optimization model to cooperatively optimize the detection sensitivity and the signal stability, carrying out weighted summation on normalized signals of the particle size subgroups to obtain comprehensive detection signal intensity, comparing the comprehensive detection signal intensity with a threshold value, and outputting a final judgment result. The technical problem that quantitative accuracy is affected by signal intensity deviation caused by vesicle particle size difference in outer vesicle marker detection is solved.

The invention relates to a serum liquid chromatography-tandem mass spectrometry pretreatment method, which comprises: (S1) mixing a serum sample and a formic acid-containing acetonitrile solution, carrying out ultrasonic treatment, vortex oscillation and centrifugation, taking the supernatant, and diluting with a formic acid-containing aqueous solution to obtain a liquid to be purified; (S2) mixing the to-be-purified liquid with PCN-777, performing ultrasonic treatment, vortex oscillation and centrifugation, and taking supernate to obtain to-be-detected liquid; the PCN-777 is a C24H23N3O16Zr3 phospholipid removal material, and the PCN-777 is a C24H23N3O16Zr3 phospholipid removal material, and the PCN-777 is a C24H23N3O16Zr3 phospholipid removal material. According to the present invention, the serum ultra-high performance liquid chromatography-tandem mass spectrometry pretreatment method is developed by using the known MOFs material PCN-777, such that different types of phospholipids in the serum can be specifically, rapidly and effectively removed, the efficient recovery and detection of pesticide and veterinary drugs can be achieved, and the interference of phospholipids can be avoided.

The invention relates to the technical field of spectral analysis and biomedical detection, and discloses an SERS (Surface Enhanced Raman Scattering) spectrum quantitative detection method and system based on interpretable stacked ensemble learning. The method comprises the following steps: acquiring SERS spectral data of serum tumor marker standard substances with different concentration gradients; performing baseline correction and normalization preprocessing on the data, performing sparse feature selection by using an LASSO algorithm, and screening out key spectral features to construct a sample data set; constructing an interpretable stacking integration model, wherein the model adopts a base learner layer and a meta learner layer; training the model by using the training set, optimizing model hyper-parameters by using a cross validation strategy, and establishing a mapping relationship between spectral features and tumor marker concentrations; and collecting SERS spectral data of a to-be-detected serum sample, extracting key spectral features, inputting the key spectral features into the trained interpretable stacked integrated model, and outputting a concentration predicted value of the tumor marker in the to-be-detected serum sample. The method has the advantages of high precision, universality and molecular level interpretability.

The invention discloses a method for detecting L-cysteine in serum based on N, S co-doped carbon nanodots, and belongs to the field of analysis and detection. The method comprises the following steps: (1) preparing carbon dots by taking beta-mercaptoethylamine and p-phenylenediamine as precursors; (2) after Fe < 3 + > is added into the carbon dot solution, a carbon dot fluorescence quenching phenomenon occurs, and a carbon dot-Fe < 3 + > mixed system is obtained; then adding L-cysteine into the carbon dot-Fe < 3 + > mixed system to gradually recover the fluorescence of the system; and (3) constructing a linear relationship between the concentration of the L-cysteine and the fluorescence recovery degree to obtain the quantitative detection model for the L-cysteine in the serum sample. According to the method, the carbon dots are prepared by taking beta-mercaptoethylamine and p-phenylenediamine as precursors for the first time, quantitative detection of L-cysteine is realized, and the method is low in cost, high in sensitivity, suitable for field rapid detection and relatively high in practical value and popularization prospect.

The invention provides a gouty arthritis diagnosis and detection kit prepared based on ceRNA, and relates to the field of nucleic acid determination kits, the gouty arthritis diagnosis and detection kit comprises a water bath tank, a mixing mechanism, an anti-blocking structure and a flow guide assembly, a top plate is inserted in the top of the water bath tank, a cover plate is hinged to the other side of the top of the water bath tank, a water injection pipeline is inserted in the bottom of the side edge of the water bath tank, and the water injection pipeline is hinged to the other side of the top of the water bath tank. According to the present invention, with the help of the two mixing sleeves in the mixing structure, the diluent and the serum sample are subjected to reciprocating flow, and the diluent and the serum sample are subjected to heat transfer with the synchronously stirred warm water during the flowing process, such that the diluent and the serum sample can be subjected to heat transfer so as to achieve the rapid detection; therefore, the water temperature of each part in the water bath tank can be ensured to be consistent, a large amount of diluted serum samples can be quickly heated, the pretreatment efficiency is improved, the number of detection test tubes for injection can be flexibly controlled, the water bath tank and the mixing mechanism part can be repeatedly utilized, and the equipment cost is reduced.

The invention belongs to the technical field of biological detection, and particularly relates to a method for synchronously and quantitatively detecting various folic acid metabolism related substances in trace plasma or serum, which comprises the following steps of: detecting a pretreated trace plasma or serum sample by adopting a liquid chromatography-tandem mass spectrometry method; the following nine folic acid metabolism related substances are synchronously and quantitatively detected: 5-formyl tetrahydrofolic acid, folic acid, 5-methyl tetrahydrofolic acid, S-adenosine-L-methionine, S-adenosine-L-homocysteine, vitamin B12, pyridoxamine, pyridoxine and pyridoxal. The invention further relates to application of the detection method in related detection of child neurodevelopment. According to the detection method, only trace plasma or serum is used, methotrexate is used for replacing an expensive isotope internal standard for more economical detection, and nine folate metabolism related substances can be accurately quantified at the same time. Therefore, the detection method disclosed by the invention has important clinical significance and wide market application prospect.

The present invention relates to a pretreatment method for serum liquid chromatography-tandem mass spectrometry analysis, comprising the following steps: (S1) mixing a serum sample with an acetonitrile solution containing formic acid, ultrasonicating, vortexing, and centrifuging, taking the supernatant and diluting it with an aqueous solution containing formic acid to obtain a liquid to be purified; (S2) mixing the liquid to be purified with PCN-777, ultrasonicating, vortexing, and centrifuging, taking the supernatant and obtaining a liquid to be tested; the PCN-777 is C 24 H 23 N3O 16 Zr3 phospholipid removal material, the PCN-777 is C 24 H 23 N3O 16 Zr3. The present invention uses a known MOFs material PCN-777 to develop a pretreatment method for serum ultra-high performance liquid chromatography-tandem mass spectrometry analysis, which can specifically, quickly and effectively remove different types of phospholipids in serum, and achieve efficient recovery and detection of pesticides and veterinary drugs, avoiding interference from phospholipids.

The invention discloses a terahertz metamaterial sensing device and a blood glucose concentration detection method, and belongs to the field of terahertz science and technology. The terahertz metamaterial sensing device comprises an upper-layer asymmetric arc-shaped silicon column array and a lower-layer silicon substrate; the asymmetric arc-shaped silicon column array is composed of a plurality of arc-shaped silicon column unit structures with one long arc-shaped silicon column unit structure and one short arc-shaped silicon column unit structure. The long arc-shaped silicon column and the short arc-shaped silicon column have the same circle center and radius, and the arc length of the long arc-shaped silicon column is longer than that of the short arc-shaped silicon column; 3-aminopropyltriethoxysilane and glucose oxidase are used for carrying out surface functional modification on the asymmetric arc-shaped silicon column array and the silicon substrate. The device can be used for sensing and detecting blood glucose in a clinical serum sample, the concentration information of the blood glucose in the sample is obtained through the frequency shift of the resonance peak of the device, and the real-time, label-free and nondestructive detection of the sample is realized while the detection sensitivity is improved.

The invention relates to the field of biological detection, in particular to application of IGSF1 protein as a cardiac function recovery marker. The invention provides application of protein as a marker in preparation of a product for detecting and / or diagnosing heart failure with improved ejection fraction. The protein comprises one or more of IGSF1, LIMS1, MPP1, PTX3, SLC2A3, FERMT3, ARPC1B, IGHG1, PTGS1, ACTN1 and RTN4, and is characterized in that the protein comprises one or more of the IGSF1, the LIMS1, the MPP1, the PTX3, the SLC2A3, the FERMT3, the ARPC1B, the IGHG1 The invention provides a novel serum marker, the expression level of the novel serum marker can predict heart failure patients with reduced ejection fraction and heart function recovery potential with high precision, and the change of the novel serum marker is earlier than the change of ejection fraction. According to the invention, a non-invasive standardized detection process based on a serum sample is established, all levels of medical institutions are adapted, and early and non-invasive prediction of the heart function recovery potential of the heart failure patient is realized.

The invention discloses a stem cell metabolism marker omics analysis method, device, equipment and medium, relates to the technical field of biomedicine, is applied to a computer device, and comprises the following steps: carrying out non-targeted detection on a to-be-detected sample of a target object to obtain an original mass spectrum; wherein the sample to be detected is a serum sample or a cell sample; preprocessing the original mass spectrogram to obtain a metabolite matrix in a standardized format; performing principal component analysis and partial least square discriminant analysis on the metabolite matrix, and determining a metabolic marker from the metabolite matrix according to an obtained analysis result; obtaining fragment information of the metabolic marker based on a collision-induced dissociation mode, and searching for a structural annotation of the metabolic marker from a human metabolome database based on the fragment information; and constructing a metabolic pathway map of the metabolic marker according to the structural annotation of the metabolic marker. The accuracy of omics analysis of the stem cell metabolism marker is improved.

The present invention provides a homocysteine ​​electrochemical sensor, and its preparation method and application. The preparation method of the homocysteine ​​electrochemical sensor of the present invention comprises the following steps: adding a dispersion containing carbon nanomaterials to the surface of a glassy carbon electrode, baking and drying, to obtain a carbon nanomaterial-modified electrode; then placing the carbon nanomaterial-modified electrode in a gold salt aqueous solution, and using an electroplating method to deposit nanogold on the surface of the carbon nanomaterial-modified electrode, to obtain a homocysteine ​​electrochemical sensor; the high conductivity of gold nanoparticles is of great significance for improving the electrocatalytic performance of the composite material for homocysteine. The homocysteine ​​electrochemical sensor prepared by the present application has low cost, low detection limit, and good stability. In addition, the spiked recovery rate of homocysteine ​​in serum samples is good, which provides potential application value for the reliable determination of homocysteine ​​in biological systems and the study of homocysteine-related diseases.

The invention provides a method for detecting the blood concentration of elacycline in serum. The method comprises the following steps: pretreating a human serum sample; then detecting by adopting liquid chromatography-mass spectrometry, wherein a liquid chromatography condition mobile phase comprises ultrapure water (a mobile phase A) containing 0.1% of formic acid and acetonitrile (a mobile phase B); the temperature of the chromatographic column is kept at 45 DEG C, and the sample size is 2L; the flow velocity of the mobile phase is set to be 0.3 mL / min, and the total operation time is 4.5 minutes; in mass spectrum conditions, a positive electrospray ionization mode is adopted, multiple reaction monitoring (MRM) is adopted, and multi-reaction monitoring is adopted as a scanning mode. The method is high in sensitivity, the lowest quantitative concentration can reach 50 ng / mL, and accurate, rapid and sensitive determination of the elacycline in the human serum can be realized.

The invention discloses a cadmium ion and lead ion detection system and method based on CRISPR and deoxyribozyme, and the method comprises the following steps: forming active deoxyribozyme by using target ions and a recognition probe, cutting a redundant sequence in a substrate probe, releasing a semi-activator, and cooperatively activating the activity of CRISPR-Cas12a with the other semi-activator in the system. According to the system, the signal-to-noise ratio and the sensitivity of detection are improved by utilizing the effect of inhibiting cooperative activation by redundant fragments in semi-activators. According to the detection method, nano material modification on the substrate probe is not needed, magnetic separation is not needed, and the detection cost is reduced. The detection process only needs two steps of room temperature incubation reaction, and the two steps are carried out in one reaction tube, so that cross contamination possibly caused by multi-tube reaction is avoided, and the detection process is simplified. The method can be applied to detection of cadmium ions and lead ions in rice or serum samples, and has wide application prospects in the fields of food safety, medical detection and the like.

The invention relates to the technical field of pathogen detection, in particular to a rapid pathogen detection system based on nanopore sequencing, which comprises an acquisition and pretreatment module, which is used for precipitating and centrifuging serum, carrying out layered monitoring, carrying out supernate separation and concentration, and measuring pH value and temperature. According to the invention, the serum is precipitated and centrifuged, and layered monitoring is combined, so that the layered state of the serum sample in the centrifugation process is visualized, and the stability of precipitated particles and the separation precision of supernate are improved. And in the supernatant concentration link, the dynamic monitoring and optimization of the sample purity are realized by measuring the pH value and the temperature and combining the recording of the protein concentration and the turbidity value. Absorbance and viscosity measurement are combined, so that the change of liquid properties can be captured in real time and compared with a pathogen directory range threshold value, and an abnormal sample can be recognized in an early stage.

The invention discloses a combined reagent for detecting fungus (1-3)-beta-D glucan, a kit and a detection method of fungus (1-3)-beta-D glucan, and belongs to the technical field of biomedical detection. The serum sample treatment liquid comprises a carbonate buffer solution with the pH value of 9.5-10.5, bacillus licheniformis protease, CHAPS, a surfactant and a preservative. The protein denaturing agent stop buffer comprises a phosphate buffer, a protease inhibitor, BSA and other components. Under the mild weak alkaline condition, the combined action of protease and a denaturant is utilized, a fungus (1-3)-beta-D glucan antigen-antibody compound in serum is efficiently dissociated, an antibody is irreversibly inactivated, and meanwhile the antigen activity is kept. The method has the advantages of simple operation, no need of heating, centrifugation or strong corrosive reagents, high safety, no precipitation and no gel of the treated sample, and suitableness for subsequent immunological detection. The invention further provides a detection kit containing the solution and a corresponding detection method, and the detection accuracy and efficiency are remarkably improved.

This invention discloses a method and sensor for adiponectin detection using a polyaniline and polyacrylic acid-modified wire mesh carbon electrode, relating to the field of adiponectin detection technology. The method involves electrochemically activating the wire mesh carbon electrode, electropolymerizing it to form a polyaniline-polyacrylic acid composite modification layer, immobilizing adiponectin monoclonal antibody after activation with N-hydroxysuccinimide and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, blocking the antibody with bovine serum albumin, and reacting it with a serum sample. The adiponectin concentration is determined based on the peak potential shift and peak current change. This invention simultaneously achieves both conductive transport and antibody immobilization, reduces non-specific adsorption and serum interference, and improves detection sensitivity, repeatability, and quantitative accuracy.

The invention discloses a plasma or serum exosome separation method which comprises the following steps: firstly, coupling an antibody for resisting four transmembrane protein CD81 on the surface of an exosome by using a magnetic bead to form an immunomagnetic bead; pretreating a serum / plasma sample, enriching exosomes, co-incubating with the immunomagnetic beads, washing the magnetic beads after incubation capture is completed, and washing off uncombined impurities; after being captured, the exosome can be directly cracked, the magnetic beads are removed for downstream experiments, or the magnetic beads are eluted to obtain the complete exosome. The exosome affinity antibody is matched with the magnetic beads, the plasma / serum sample exosome is separated, the unique affinity separation technology not only can remove high-abundance protein in the serum / plasma sample, but also can eliminate other vesicles with similar membrane structures with the exosome, so that the purity of the separated exosome is far higher than that of the exosome obtained by other separation methods.

The present disclosure provides methods for assessing mucosal healing in a patient with Crohn's Disease. The methods include detecting expression levels of analytes in a serum sample from a patient, and applying a mathematical algorithm to the expression levels, thereby producing a Mucosal Healing Index score for the patient. The present disclosure also provides kits that include two or more binding partners, each or which is capable of binding a different analyte measured in the disclosed mucosal healing assessment methods.

The application relates to a centrifugal device and method for detecting animal serum samples and relates to the technical field of serum sample detection. The device comprises a body, a spline is rotationally connected to the bottom of the body cavity through a motor, a bracket is connected to the upper end of the spline in a concave-convex abutting mode, an electrically conductive slip ring is arranged on the outside of the motor output end of the bottom of the body cavity, and a stator on the outside of the electrically conductive slip ring is fixed in the cavity of the body through a connecting rod. Through cooperation of a clamping assembly, a sleeve, a clamping seat and a tube clamp, the clamping seat is driven to rotate by rotating the rotating sleeve, the tube clamp is opened and closed in an interlaced mode through meshing of the connecting plate and the gear, various sizes of serum test tubes can be clamped, special parts need not be replaced, work efficiency is improved, meanwhile, when the number of test tubes is odd, the gravity sensor senses the weight, the electric push rod pushes the connecting frame on the symmetrical position to adjust the position, the gravity center is adjusted through cooperation of the rotating structure, the bracket is balanced, sample spilling and pollution are avoided.

The present disclosure relates to a biomarker for distinguishing between depression and bipolar disorder and uses thereof, elucidating a composition for distinguishing between depression and bipolar disorders and a method for providing information for distinguishing between depression and bipolar disorder, using same, wherein the composition is based on a biomarker composition comprising eotaxin, nerve growth factors (NGF), tumor necrosis factor-α (TNF-α), glial cell derived neurotrophic factor (GDNF), interleukin-1β (IL-1β), and serum soluble CD40 Ligand (sCD40L) within a serum sample and includes an agent for measuring the expression level of each of the six biomarker proteins.

The invention relates to the technical field of biotechnology and medical detection, in particular to an ovarian cancer early-stage accurate screening method based on triple lipid metabolite chemical crosslinking, which comprises the following steps: sample collection: collecting a serum sample of a person to be detected; lipid metabolite extraction: extracting lipid metabolite from the serum sample; detection of triple lipid metabolites: simultaneously detecting the contents of sphingomyelin (SM), phosphatidylcholine (PC) and cholesteryl ester (CE) in the lipid metabolites by adopting a liquid chromatography-mass spectrometry technology, and by simultaneously detecting the three lipid metabolites of sphingomyelin (SM), phosphatidylcholine (PC) and cholesteryl ester (CE) and carrying out chemical cross-linking analysis, the content of the triple lipid metabolites in the lipid metabolites can be detected; and calculating the triple lipid metabolite index (TLMI), so that the abnormal lipid metabolism condition of the ovarian cancer patient can be more comprehensively and accurately reflected, and the sensitivity and the specificity of early screening of the ovarian cancer are improved.

The invention belongs to the technical field of biomedical detection, and particularly discloses a nucleic acid aptamer for specifically recognizing serum alpha fetoprotein and application of the nucleic acid aptamer. The nucleotide sequence of the nucleic acid aptamer comprises a sequence as shown in SEQ ID No.1, or has more than 90% of homology with the sequence as shown in SEQ ID No.1, or one or more nucleotides are deleted or added in the sequence as shown in SEQ ID No.1. The nucleic acid aptamer can realize specific efficient recognition of AFP protein, also shows extremely high selectivity in a complex serum sample environment, eliminates non-specific adsorption interference of homologous protein and other serum interference protein, greatly reduces the false positive rate, and improves the accuracy and specificity of clinical detection. And the material constructed by directionally functionalizing the aptamer on the surface of the magnetic nano-carrier has rapid magnetic response performance, separation and enrichment of target protein can be realized within seconds, and the clinical diagnosis time is greatly shortened.

The invention discloses a detection method and a kit for detecting listeria monocytogenes, and relates to the technical field of biology. The kit is an indirect ELISA kit and comprises an elisa plate coated with an antigen, the amino acid sequence of the antigen is as shown in SEQ ID NO. 2. The indirect ELISA detection kit constructed by the invention only reacts with listeria monocytogenes positive serum, has no cross reaction with other serum, and has strong specificity; when the serum dilution is 1: 800, the detection result is still positive, and the sensitivity is high; the intra-batch variation coefficient ranges from 2.79% to 6.64%, the inter-batch variation coefficient ranges from 2.61% to 7.75%, and the intra-batch repeatability and the inter-batch repeatability are good; 24 serum samples are detected, and the total coincidence rate is 95.83%. The kit provided by the invention can effectively detect sample infection of Listeria monocytogenes, and has the advantages of strong specificity, high sensitivity and good repeatability.

The invention relates to an intramolecular strand displacement reaction-based microRNA detection method and kit, and the kit is characterized in that the kit comprises four single-stranded sequences forming a DNA tetrahedron, a probe S and DNA polymerase; a probe T structure is designed at the top end of the DNA tetrahedron, and the probe T is used for capture of the probe S and intramolecular strand displacement reaction triggered by microRNA to be detected. The DNA tetrahedral structure is utilized to enhance the probe fixing efficiency and stability, and the detection sensitivity is improved; signal amplification is realized through intramolecular strand displacement reaction, and the detection limit is as low as 5 * 10 <-17 > mol / L; good selectivity is achieved, and single-base mismatch sequences can be distinguished; the kit has good performance in serum samples and has practical application potential.

The present invention relates to the technical field of in-vitro testing, and in particular to a method for using a sandwich method to test a target molecule in a sample. The present invention provides a method for testing a target molecule in a sample under test, and testing is mainly performed by mean of a sandwich method, greatly improving the accuracy of testing of small molecules in serum. According to the method in the present invention, a complex-specific antibody specifically binding to a target molecule-target molecule binding protein is utilized to form a target molecule-target molecule binding protein-antibody ternary complex for testing. When a blood / serum sample containing the target molecule-target molecule binding protein is tested, in the method in the present invention, firstly, a specific dissociation solution is utilized to treat the sample under test so as to dissociate the target molecule from the target molecule-target molecule binding protein complex in the sample under test, so that the accuracy of testing of the target molecule can be further improved.

The application relates to an electrochemical sensor based on antibody-aptamer synergic recognition and a construction method and application thereof, and belongs to the technical field of electrochemical analysis and biomarker AZGP1 detection technology. The sensor has strong resistance to high-concentration endogenous interference, and has good selectivity when interference and AZGP1 exist. Compared with the prior art, the sensor has the advantages of high sensitivity, high selectivity, simple operation, rapid detection, low cost and the like, and successfully realizes the detection of AZGP1 in a clinical patient serum sample, and provides a new and efficient method for clinical detection of biological recognition molecules.

The invention discloses a detection method of vitamin K1, and belongs to the technical field of biological detection. The problems that a vitamin K1 detection method is tedious in operation, prone to being influenced by a matrix, low in sensitivity and the like are solved. The detection method comprises the following steps: (1) preparing a standard substance intermediate working solution, an isotope internal standard substance solution and a standard curve working solution of the vitamin K1; (2) treating a serum sample and a standard curve working solution: adding a 2-nitroso pyridine solution to carry out derivatization reaction; and (3) detecting the vitamin K1 by using a high performance liquid chromatography-tandem mass spectrometry method. According to the method, the 2-nitroso pyridine is used as a derivatization reagent, the vitamin K1 and the 2-nitroso pyridine are subjected to a Diels-Alder reaction to generate a new six-membered heterocycle containing N and O, the 2-nitroso pyridine can efficiently and completely react with the vitamin K1 in only 10 minutes at room temperature, the detection steps are simplified, the sample pretreatment time is shortened, and the detection efficiency is improved.